Vanguard Asset Management’s Novavax NVAX Stock Holding History

Vanguard Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$833K	Hold	88,428	–	–	﹤0.01%	1975
2026 Q1	$720K	Buy	+88,428	New	+$802K	﹤0.01%	1930

Other funds holding NVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Asset Management's NVAX Position: Q2 2026 in Review

Vanguard Asset Management held its Novavax (NVAX) position steady in Q2 2026 at 88,428 shares worth $833K. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

Vanguard Asset Management first reported a position in NVAX in Q1 2026 and has held it in 2 quarters since. 247 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Vanguard Asset Management held 88,428 shares of Novavax worth $833K as of Q2 2026.
Vanguard Asset Management left its Novavax share count unchanged in Q2 2026.
Novavax made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #1975 holding.
Vanguard Asset Management first reported a position in Novavax in Q1 2026 and has held it in 2 quarters since.
247 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.